Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Irisity | IRIS | Mar 28, 2024 | 3.95 | -0.75 |
IRLAB Therapeutics A | IRLABA | Mar 28, 2024 | 15.60 | -3.70 |
Isofol Medical | ISOFOL | Mar 28, 2024 | 0.77 | +1.85 |
ITAB Shop Concept | ITAB | Mar 28, 2024 | 20.30 | +1.75 |
iZafe Group B | IZAFEB | Mar 28, 2024 | 0.22 | -7.08 |
Jetpak Top Holding | JETPAK | Mar 28, 2024 | 95.80 | +1.48 |
JLT Mobile Computers | JLT | Mar 28, 2024 | 3.80 | +2.70 |
JM | JM | Mar 28, 2024 | 219.00 | +0.46 |
Job Solution Sweden Holding AB (publ) | JOBS | Mar 28, 2024 | 19.80 | -0.50 |
John Mattson | JOMA | Mar 28, 2024 | 56.90 | +3.08 |
JonDeTech Sensors | JDT | Mar 28, 2024 | 0.03 | 0.00 |
JS Security | JSSEC | Mar 28, 2024 | 0.20 | -0.51 |
Jumpgate | GATE | Mar 28, 2024 | 0.15 | -0.65 |
K-Fast Holding B | KFASTB | Mar 28, 2024 | 21.30 | 0.00 |
K2A Knaust & Andersson Fastigheter B | K2AB | Mar 28, 2024 | 8.90 | +5.70 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Mar 28, 2024 | 204.00 | +2.26 |
KABE Group B | KABEB | Mar 28, 2024 | 308.00 | +0.65 |
Kakel Max | KAKEL | Mar 28, 2024 | 9.65 | 0.00 |
Kallebäck Property Invest | KAPIAB | Mar 28, 2024 | 184.00 | +0.55 |
Kambi Group | KAMBI | Mar 28, 2024 | 92.40 | +0.60 |
Kancera | KAN | Mar 28, 2024 | 1.71 | -0.12 |
Karnell Group AB (publ) | KARNELB | 0.00 | 0.00 | |
Karnov Group | KAR | Mar 28, 2024 | 66.10 | +1.54 |
Karolinska Development B | KDEV | Mar 28, 2024 | 1.55 | +1.57 |
Katalysen Ventures AB | KAV | Mar 28, 2024 | 15.20 | 0.00 |
KebNi B | KEBNIB | Mar 28, 2024 | 1.44 | 0.00 |
Kentima Holding B | KENH | Mar 28, 2024 | 1.74 | 0.00 |
Kiliaro | KILI | Mar 28, 2024 | 0.82 | -1.20 |
Kindred Group SDB | KINDSDB | Mar 28, 2024 | 124.30 | -0.08 |
Kinnevik A | KINVA | Mar 28, 2024 | 120.60 | +0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.